Showing results (91-100 of 330) with videos related to

Sort By:
Pageof 33
Cancer Chemotherapy and Pharmacology|October 11, 2001
Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxyl) ethylamino-12,13-dihydro-13-(beta-D-glucopyranosyl) -5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione]] against pediatric and adult central nervous system tumor xenograftsC M Cavazos, S T Keir, T Yoshinari, et al.
Cancer Genetics and Cytogenetics|September 1, 1997
Chromosomal characteristics of childhood brain tumorsS H Bigner, R E McLendon, H Fuchs, et al.
JAMA|August 14, 1981
Impact of peer review in reduction of permanent pacemaker implantationsA B Chokshi, H S Friedman, M Malach, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1986
Prognostic implications for direct platelet-associated IgG in childhood idiopathic thrombocytopenic purpuraR Ware, T R Kinney, H S Friedman, et al.
Cancer Genetics and Cytogenetics|July 1, 1989
Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic miceS H Bigner, S C Schold, H S Friedman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosoureaG M Felker, H S Friedman, M E Dolan, et al.
Cancer Research|April 15, 1990
Amplification of the c-myc gene in human medulloblastoma cell lines and xenograftsS H Bigner, H S Friedman, B Vogelstein, et al.
Cancer Treatment Reports|December 1, 1985
Pharmacokinetics of diaziquone after three different dosage regimensT D Bjornsson, S C Schold, H S Friedman, et al.
The British Journal of Radiology|January 13, 2011
A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiformeM J Paldino, A Desjardins, H S Friedman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenograftsH S Friedman, P J Houghton, S C Schold, et al.
Pageof 33